{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:32:16Z","timestamp":1788809536393,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009086","name":"Medical University Sofia","doi-asserted-by":"publisher","award":["C-126\/04.06.2021"],"award-info":[{"award-number":["C-126\/04.06.2021"]}],"id":[{"id":"10.13039\/100009086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["KP-06-H23\/4"],"award-info":[{"award-number":["KP-06-H23\/4"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11033-023-08629-5","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T07:01:58Z","timestamp":1688713318000},"page":"7245-7252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-9390","authenticated-orcid":false,"given":"Anastasia","family":"Ormandjieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Yordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristo","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-9932","authenticated-orcid":false,"given":"Elitsa","family":"Deliverska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-7999","authenticated-orcid":false,"given":"Velizar","family":"Shivarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-9915","authenticated-orcid":false,"given":"Milena","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"8629_CR1","unstructured":"Worldwide cancer data https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data. Accessed 11.2022"},{"key":"8629_CR2","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3389\/fonc.2020.01669","volume":"10","author":"Y Du","year":"2020","unstructured":"Du Y, Shao S, Lv M et al (2020) Radiotherapy Versus surgery\u2013which is better for patients with T1-2N0M0 glottic laryngeal squamous cell carcinoma? Individualized survival prediction based on web-based nomograms. Front Oncol 10:1669. https:\/\/doi.org\/10.3389\/fonc.2020.01669","journal-title":"Front Oncol"},{"issue":"10","key":"8629_CR3","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1002\/ijc.33192","volume":"147","author":"L Song","year":"2020","unstructured":"Song L, Zhang S, Yu S et al (2020) Cellular heterogeneity landscape in laryngeal squamous cell carcinoma. Int J Cancer 147(10):2879\u20132890. https:\/\/doi.org\/10.1002\/ijc.33192","journal-title":"Int J Cancer"},{"issue":"1","key":"8629_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21386","volume":"67","author":"CE Steuer","year":"2017","unstructured":"Steuer CE, El-Deiry M, Parks JR et al (2017) An update on larynx cancer. CA Cancer J Clin 67(1):31\u201350. https:\/\/doi.org\/10.3322\/caac.21386","journal-title":"CA Cancer J Clin"},{"key":"8629_CR5","doi-asserted-by":"publisher","first-page":"606010","DOI":"10.3389\/fonc.2021.606010","volume":"11","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Wang H, Zhao Q et al (2021) Evaluation of risk factors for laryngeal squamous cell carcinoma: a Single-Center Retrospective Study. Front Oncol 11:606010. https:\/\/doi.org\/10.3389\/fonc.2021.606010","journal-title":"Front Oncol"},{"issue":"1","key":"8629_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/lio2.353","volume":"5","author":"CR Bradford","year":"2020","unstructured":"Bradford CR, Ferlito A, Devaney KO et al (2020) Prognostic factors in laryngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol 5(1):74\u201381. https:\/\/doi.org\/10.1002\/lio2.353","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"5","key":"8629_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00262-021-03071-7","volume":"71","author":"X Wang","year":"2020","unstructured":"Wang X, Cao K, Guo E et al (2020) Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment. Cancer Immunol Immunother 71(5):1199\u20131220. https:\/\/doi.org\/10.1007\/s00262-021-03071-7","journal-title":"Cancer Immunol Immunother"},{"issue":"459","key":"8629_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aat7807","volume":"10","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Chan TA, Kroemer G et al (2018) The hallmarks of successful anticancer immunotherapy. Sci Transl Med 10(459):1\u201315. https:\/\/doi.org\/10.1126\/scitranslmed.aat7807","journal-title":"Sci Transl Med"},{"issue":"11","key":"8629_CR9","doi-asserted-by":"publisher","first-page":"e26491","DOI":"10.4161\/onci.26491","volume":"2","author":"G Kochan","year":"2013","unstructured":"Kochan G, Escors D, Breckpot K et al (2013) Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology 2(11):e26491. https:\/\/doi.org\/10.4161\/onci.26491","journal-title":"Oncoimmunology"},{"issue":"8","key":"8629_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00018-022-04491-z","volume":"79","author":"A Arnaiz-Villena","year":"2022","unstructured":"Arnaiz-Villena A, Suarez-Trujillo F, Juarez I et al (2022) Evolution and molecular interactions of major histocompatibility complex (MHC)-G, -E and -F genes. Cell Mol Life Sci 79(8):464. https:\/\/doi.org\/10.1007\/s00018-022-04491-z","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"8629_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.14670\/HH-26.1487","volume":"26","author":"TG Silva","year":"2011","unstructured":"Silva TG, Crispim JCO, Miranda FA et al (2011) Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness. Histol Histopathol 26(12):1487\u20131497. https:\/\/doi.org\/10.14670\/HH-26.1487","journal-title":"Histol Histopathol"},{"key":"8629_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.13426","volume":"5","author":"D Schmiedel","year":"2016","unstructured":"Schmiedel D, Tai J, Yamin R et al (2016) The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. eLife 5:1\u201318. https:\/\/doi.org\/10.7554\/eLife.13426","journal-title":"eLife"},{"issue":"4","key":"8629_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/1573395511208040006","volume":"8","author":"M Muro","year":"2015","unstructured":"Muro M, Lopez-Hernandez R, Llorente S et al (2015) MICA Molecules in Disease and Transplantation, a double-edged Sword? Curr Immunol Rev 8(4):307\u2013325. https:\/\/doi.org\/10.2174\/1573395511208040006","journal-title":"Curr Immunol Rev"},{"issue":"2","key":"8629_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/sji.12072","volume":"78","author":"G Chitadze","year":"2013","unstructured":"Chitadze G, Bhat J, Lettau M et al (2013) Generation of Soluble NKG2D Ligands: proteolytic cleavage, Exosome Secretion and Functional Implications. Scand J Immunol 78(2):120\u2013129. https:\/\/doi.org\/10.1111\/sji.12072","journal-title":"Scand J Immunol"},{"issue":"2","key":"8629_CR15","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.4238\/2015.June.29.16","volume":"14","author":"YK Zhao","year":"2015","unstructured":"Zhao YK, Jia CM, Yuan GJ et al (2015) Expression and clinical value of the soluble major histocompatibility complex class I-related chain A molecule in the serum of patients with renal tumors. Genet Mol Res 14(2):7233\u20137240. https:\/\/doi.org\/10.4238\/2015.June.29.16","journal-title":"Genet Mol Res"},{"issue":"8","key":"8629_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jop.13185","volume":"50","author":"M Ivanova","year":"2021","unstructured":"Ivanova M, Al Hadra B, Yordanov S et al (2021) Associations of high-resolution-typing-defined MICA and MICB polymorphisms, and the levels of soluble MICA and MICB with oral squamous cell carcinoma in bulgarian patients. J Oral Pathol Med 50(8):758\u2013765. https:\/\/doi.org\/10.1111\/jop.13185","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"8629_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt WM, Patel SG, O\u2019Sullivan B et al (2017) Head and neck cancers\u2014major changes in the american Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122\u2013137. https:\/\/doi.org\/10.3322\/caac.21389","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8629_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-017-1496-0","volume":"18","author":"Y Fan","year":"2017","unstructured":"Fan Y, Song YQ (2017) PyHLA: tests for the association between HLA alleles and diseases. BMC Bioinformatics 18(1):1\u20135. https:\/\/doi.org\/10.1186\/s12859-017-1496-0","journal-title":"BMC Bioinformatics"},{"key":"8629_CR19","unstructured":"Sinnwell JP, Schaid DJ (2022) Haplo.stats: statistical analysis of haplotypes with traits and covariates when linkage phase is ambiguous. R package version 1.8.9. https:\/\/cran.r-project.org\/package=haplo.stats"},{"key":"8629_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-0998.2010.02847.x","volume":"10","author":"L Excoffier","year":"2010","unstructured":"Excoffier L, Lischer HEL (2010) Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol Ecol Resour 10:564\u2013567. https:\/\/doi.org\/10.1111\/j.1755-0998.2010.02847.x","journal-title":"Mol Ecol Resour"},{"issue":"29","key":"8629_CR21","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.2015.61.1509","volume":"33","author":"RL Ferris","year":"2015","unstructured":"Ferris RL (2015) Immunology and Immunotherapy of Head and Neck Cancer. J Clin Oncol 33(29):3293\u20133304. https:\/\/doi.org\/10.1200\/JCO.2015.61.1509","journal-title":"J Clin Oncol"},{"issue":"5","key":"8629_CR22","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI123955","volume":"129","author":"T Kamiya","year":"2019","unstructured":"Kamiya T, Seow SV, Wong D et al (2019) Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest 129(5):2094\u20132106. https:\/\/doi.org\/10.1172\/JCI123955","journal-title":"J Clin Invest"},{"key":"8629_CR23","doi-asserted-by":"publisher","unstructured":"Wagner B, Nardi F, Schramm S (2016) HLA-E allelic genotype correlates with HLA\u2010E plasma levels and predicts early progression in chronic lymphocytic leukemia. 123(5):814\u2013823. https:\/\/doi.org\/10.1002\/cncr.30427","DOI":"10.1002\/cncr.30427"},{"issue":"5","key":"8629_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.00964","volume":"10","author":"A Lin","year":"2019","unstructured":"Lin A, Yan WH (2019) The emerging roles of human leukocyte antigen-F in immune modulation and viral infection. Front Immunol 10(5):1\u20137. https:\/\/doi.org\/10.3389\/fimmu.2019.00964","journal-title":"Front Immunol"},{"issue":"3","key":"8629_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.lungcan.2011.04.006","volume":"74","author":"A Lin","year":"2011","unstructured":"Lin A, Zhang X, Ruan YY et al (2011) HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. Lung Cancer 74(3):504\u2013509. https:\/\/doi.org\/10.1016\/j.lungcan.2011.04.006","journal-title":"Lung Cancer"},{"key":"8629_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/359748","volume":"2014","author":"N Rouas-Freiss","year":"2014","unstructured":"Rouas-Freiss N, Moreau P, LeMaoult J et al (2014) The dual role of HLA-G in Cancer. J Immunol Res 2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/359748","journal-title":"J Immunol Res"},{"key":"8629_CR27","doi-asserted-by":"publisher","unstructured":"Paganini J, Abi-Rached L, Gouret P et al (2019) HLAIb worldwide genetic diversity: New HLA-H alleles and haplotype structure description. Mol Immunol 1;112:40\u201350. https:\/\/doi.org\/10.1016\/j.molimm.2019.04.017","DOI":"10.1016\/j.molimm.2019.04.017"},{"issue":"1","key":"8629_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02986","volume":"10","author":"F Jordier","year":"2020","unstructured":"Jordier F, Gras D, De Grandis M et al (2020) HLA-H: transcriptional activity and HLA-E mobilization. Front Immunol 10(1):1\u20137. https:\/\/doi.org\/10.3389\/fimmu.2019.02986","journal-title":"Front Immunol"},{"issue":"5","key":"8629_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2018.00168","volume":"8","author":"G Wichmann","year":"2018","unstructured":"Wichmann G, Lehmann C, Herchenhahn C et al (2018) Development of a human leukocyte antigen score to predict progression-free survival in head and neck squamous cell carcinoma patients. Front Oncol 8(5):1\u20138. https:\/\/doi.org\/10.3389\/fonc.2018.00168","journal-title":"Front Oncol"},{"issue":"3","key":"8629_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.humimm.2006.02.008","volume":"67","author":"HR Salih","year":"2006","unstructured":"Salih HR, Goehlsdorf D, Steinle A (2006) Release of MICB Molecules by Tumor cells: mechanism and Soluble MICB in Sera of Cancer Patients. Hum Immunol 67(3):188\u2013195. https:\/\/doi.org\/10.1016\/j.humimm.2006.02.008","journal-title":"Hum Immunol"},{"key":"8629_CR31","doi-asserted-by":"publisher","unstructured":"Dyckhoff G, Herold-Mende C, Scherer S (2022) Human leucocyte antigens as prognostic markers in Head and Neck squamous cell carcinoma. Cancers (Basel) 14(15). https:\/\/doi.org\/10.3390\/cancers14153828","DOI":"10.3390\/cancers14153828"},{"issue":"1","key":"8629_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ijc.27621","volume":"132","author":"X Zhang","year":"2013","unstructured":"Zhang X, Lin A, Zhang JG et al (2013) Alteration of HLA-F and HLA i antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma. Int J Cancer 132(1):82\u201389. https:\/\/doi.org\/10.1002\/ijc.27621","journal-title":"Int J Cancer"},{"issue":"5\u20136","key":"8629_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00251-019-01112-1","volume":"71","author":"GGT H\u00f2","year":"2019","unstructured":"H\u00f2 GGT, Heinen FJ, Huyton T et al (2019) HLA-F*01:01 presents peptides with N-terminal flexibility and a preferred length of 16 residues. Immunogenetics 71(5\u20136):353\u2013360. https:\/\/doi.org\/10.1007\/s00251-019-01112-1","journal-title":"Immunogenetics"},{"key":"8629_CR34","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1038\/s41467-019-10489-2","volume":"10","author":"Y Sharma","year":"2019","unstructured":"Sharma Y, Miladi M, Dukare S et al (2019) A pan-cancer analysis of synonymous mutations. Nat Commun 10:2569. https:\/\/doi.org\/10.1038\/s41467-019-10489-2","journal-title":"Nat Commun"},{"issue":"5","key":"8629_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1399-0039.2008.01138.x","volume":"72","author":"LC Sullivan","year":"2008","unstructured":"Sullivan LC, Clements CS, Rossjohn J et al (2008) The major histocompatibility complex class ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 72(5):415\u2013424. https:\/\/doi.org\/10.1111\/j.1399-0039.2008.01138.x","journal-title":"Tissue Antigens"},{"issue":"1","key":"8629_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/2314808X.2021.1943804","volume":"8","author":"G Barakat","year":"2021","unstructured":"Barakat G, Elsharkawy A, Nabiel Y (2021) Human leucocyte antigen\u2013G gene polymorphism in laryngeal squamous cell carcinoma patients in Mansoura University Hospitals. Egypt J Basic Appl Sci 8(1):214\u2013221. https:\/\/doi.org\/10.1080\/2314808X.2021.1943804","journal-title":"Egypt J Basic Appl Sci"},{"issue":"3","key":"8629_CR37","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.oraloncology.2006.03.003","volume":"43","author":"J Reinders","year":"2007","unstructured":"Reinders J, Rozemuller EH, Otten HG et al (2007) HLA and MICA associations with head and neck squamous cell carcinoma. Oral Oncol 43(3):232\u2013240. https:\/\/doi.org\/10.1016\/j.oraloncology.2006.03.003","journal-title":"Oral Oncol"},{"issue":"3","key":"8629_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.humimm.2006.02.006","volume":"67","author":"J Reinders","year":"2006","unstructured":"Reinders J, Rozemuller EH, van der Ven KJW et al (2006) MHC class I chain-related gene a diversity in Head and Neck squamous cell carcinoma. Hum Immunol 67(3):196\u2013203. https:\/\/doi.org\/10.1016\/j.humimm.2006.02.006","journal-title":"Hum Immunol"},{"key":"8629_CR39","doi-asserted-by":"publisher","first-page":"105256","DOI":"10.1016\/j.oraloncology.2021.105256","volume":"116","author":"R Tani","year":"2021","unstructured":"Tani R, Ito N, Matsui K et al (2021) MICA A5.1 homozygous genotype is associated with a risk for early-onset oral cancer. Oral Oncol 116:105256. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105256","journal-title":"Oral Oncol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08629-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08629-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08629-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T01:02:26Z","timestamp":1693098146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08629-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["8629"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08629-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2743540\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The principles of the Declaration of Helsinki were strictly followed during the study. Ethical approval was granted for this study by Research Ethics Committee at Medical University - Sofia with the approval number \u211615\/19.05.2021.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement"}},{"value":"All patients and healthy controls provided informed consent for genetic testing as part of the institutional review board\u2019s approved standard-operating procedures at our institutions.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}]}}